- Country: USA
- Summary: TECHNOLOGY TRANSFER OPPORTUNITY: Noninvasive Therapy for Cartilage Regeneration (MSC-TOPS-96)
- UST Ref No: 107514506
- Deadline: 13 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: T2P-JSC-00052
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
NASA-s Technology Transfer Program solicits inquiries from companies interested in obtaining license rights to commercialize, manufacture and market the following technology. License rights may be issued on an exclusive or nonexclusive basis and may include specific fields of use. NASA provides no funding in conjunction with these potential licenses.
THE TECHNOLOGY:
Innovators at NASA Johnson Space Center researching time-variance magnetic field (TVMF) therapies have developed a pulsed electromagnetic field (PEMF) device that can alleviate cartilage degradation in synovial joints by promoting the growth of new cartilage. Joint disorders, whether induced by rheumatism, joint dysplasia, trauma, or surgery, often degrade cartilage and result in intense patient pain. Noninvasive and painless regeneration of a patient-s own tissue offers fewer side-effects than surgical joint replacement or tissue engineering procedures. The PEMF device could simply be wrapped around synovial joints where cartilage-degrading inflammation is located. This pulsed electromagnetic field technology is at a technology readiness level (TRL) 6 (system/sub-system model or prototype demonstration in an operational environment) and the related patent is available for licensing. Please note that NASA does not manufacture products itself for commercial sale.
To express interest in this opportunity, please submit a license application through NASA-s Automated Technology Licensing Application System (ATLAS) by visiting https://technology.nasa.gov/patent/MSC-TOPS-96
If you have any questions, please e-mail NASA-s Technology Transfer Program at Agency-Patent-Licensing@mail.nasa.gov with the title of this Technology Transfer Opportunity as listed in this SAM.gov notice and your preferred contact information. For more information about licensing other NASA-developed technologies, please visit the NASA Technology Transfer Portal at https://technology.nasa.gov/
These res... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTECHNOLOGY TRANSFER OPPORTUNITY: Noninvasive Therapy for Cartilage Regeneration (MSC-TOPS-96) - USA Tender
The NATIONAL AERONAUTICS AND SPACE ADMINISTRATION, a Government sector organization in USA, has announced a new tender for TECHNOLOGY TRANSFER OPPORTUNITY: Noninvasive Therapy for Cartilage Regeneration (MSC-TOPS-96). This tender is published on USARFP under UST Ref No: 107514506 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-13.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
